Edition:
United States

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

0.53USD
3:21pm EDT
Change (% chg)

$0.01 (+1.90%)
Prev Close
$0.52
Open
$0.52
Day's High
$0.53
Day's Low
$0.50
Volume
19,136
Avg. Vol
111,677
52-wk High
$2.00
52-wk Low
$0.45

Chart for

About

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical... (more)

Overall

Beta: 1.93
Market Cap(Mil.): $7.24
Shares Outstanding(Mil.): 13.92
Dividend: --
Yield (%): --

Financials

  ABIO.OQ Industry Sector
P/E (TTM): -- 30.14 32.45
EPS (TTM): -1.09 -- --
ROI: -113.36 12.95 12.63
ROE: -113.55 14.92 14.80

BRIEF-Arca Biopharma Q1 Loss Per Share $0.20

* ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 08 2018

BRIEF-Arca Biopharma And Medtronic Extend Gencaro Clinical Trial Collaboration Agreement

* ARCA BIOPHARMA AND MEDTRONIC EXTEND GENCARO CLINICAL TRIAL COLLABORATION AGREEMENT

Apr 23 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $43.19 -0.32
Novartis AG (NOVN.S) CHF81.74 +0.28
Merck & Co., Inc. (MRK.N) $69.98 -0.44
Roche Holding Ltd. (ROG.S) CHF236.50 -0.15
Roche Holding Ltd. (RO.S) CHF238.60 -1.20
Abbott Laboratories (ABT.N) $68.43 +0.02
Bayer AG (BAYGn.DE) €74.03 +0.73
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €75.12 +0.22
Eli Lilly And Co (LLY.N) $105.64 -1.24

Earnings vs. Estimates